PharmaShots | Incisive News in 3 Shots

Subscribe Now

Selecta Biosciences

Selecta Biosciences’s Reports the US FDA's Clinical Hold on the P-I/II Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia

Selecta Biosciences’s Reports the US FDA's Clinical Hold on the P-I/II Clinical Trial of SEL-302 for the Treatment of Methylmaloni...

November 26, 2021

PharmaShots Weekly Snapshot (Sept 28 - Oct 1, 2020)

PharmaShots Weekly Snapshot (Sept 28 - Oct 1, 2020)

October 2, 2020

$Sobi & Selecta Report Results of SEL-212 in P-II COMPARE Study for Chronic Refractory Gout$

Sobi & Selecta Report Results of SEL-212 in P-II COMPARE Study for Chronic Refractory Gout

October 1, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us